Reassessing Utility in the MyLungHealth Trial
To the Editor Kukhareva et al1 reported that a multilevel decision support intervention increased lung cancer screening (LCS) eligibility identification and ordering. Although commendable, we have concerns regarding the statistical methodology and clinical interpretation of the study.
Authors
- Liqun Zhang
- Fang Li
Institutions
- Liaoning Cancer Hospital & Institute (CN)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2026-04-02
- DOI
- https://doi.org/10.1001/jamaoncol.2026.0542
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 0.00